In June, an FDA advisory committee voted against approval of midomafetamine capsules (MDMA) for adults living with posttraumatic stress disorder (PTSD).
Giuliana Grossi
Advertisement
Articles by Giuliana Grossi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New lean MASH mouse model could guide more targeted liver disease treatment in humans
2
FAQ: State PBM reform in 2026—What's new since spring
3
A conversation with Jordan Herring, Ph.D., and Carlos E. Rodriguez-Diaz, Ph.D., MPHE, MCHES, about the relationship between HIV incidence in Hispanic communities and immigration policy
4
When the referral isn't the finish line: Making SDOH programs actually close care gaps
5